Effect of switching to once-weekly semaglutide on non-alcoholic fatty liver disease: the SWITCH-SEMA 1 subanalysis
Overall, these results suggest that GLP-1 medications like semaglutide may influence both eating and substance use behaviors, offering potential benefits for individuals with alcohol use disorder
Evaluating Online GLP-1 Providers: A Clinical Credibility Framework Before purchasing any GLP-1 medication online, assess whether the provider conducts a clinical intake, requires baseline metabolic labs, and employs licensed prescribers (MDs, DOs, NPs, PAs)
Favorable 99% Mixed 1% Unfavorable overall 0% Most reported benefits Benefits users selected when logging a favorable or mixed check-in
Tirzepatide carries a lower risk of dangerously low blood sugar compared to older medications like sulfonylureas
If cost is a concern, talk to your provider about savings options like manufacturer discount cards, assistance programs, or specialty-compounded alternatives